USANA Health Sciences Reports Fourth Quarter and Full-Year Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq fall as megacap tech drags; Iran developments watched
- Oil falls 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
USANA Health Sciences (USNA) Misses Q4 EPS by 16c; Issues Light FY16 Outlook
February 9, 2016 4:18 PM ESTUSANA Health Sciences (NYSE: USNA) reported Q4 EPS of $1.83, $0.16 worse than the analyst estimate of $1.99. Revenue for the quarter came in at $232.6 million versus the consensus estimate of $238.91 million.
GUIDANCE:
USANA Health Sciences sees FY2016 EPS of $7.60-$8.15, versus the... More
